← Eichor
Condition: Antiplatelet Agents Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Antiplatelet Agents

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

IndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly Patients With Acute Coronary Syndrome
Phase 4 · 1 location(s) · Shanghai Zhongshan Hospital · NCT06451198Platelet Inhibitor Treated Patients With Head Injury Trauma Meeting NICE Criteria : is the CT-scan Mandatory ?
Phase N/A · 12 location(s) · Rennes University Hospital · NCT03687528Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic
NA · 1 location(s) · Rajaie Cardiovascular Medical and Research Center · NCT06541691Antiplatelet Therapy and Endothelial-stabilizing Agents in Cerebral Small Vessel Diseases
Phase N/A · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT06715007Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II
Phase 1 · 1 location(s) · Montreal Heart Institute · NCT05702463AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE
Phase 4 · 2 location(s) · University Hospital, Bordeaux · NCT04796714Endoscopic Evaluation for Iron Deficiency Anemia in Patients on Antithrombotic Therapy
NA · 1 location(s) · Centre intégré universitaire de santé et de services sociaux · NCT07089030Characterization of Exosomes Platelets-released
Phase N/A · 1 location(s) · Centro Cardiologico Monzino · NCT06298682Comparison of Antiplatelet Effects of Sotagliflozin to FDA-approved Antiplatelet Drugs
EARLY_Phase 1 · 1 location(s) · University of Michigan · NCT06933056Effects of Antiplatelet and Antioxidant Agents on Drusen Progression: A Pilot, Prospective Cohort Study
Phase 3 · 1 location(s) · Navamindradhiraj University · NCT06165068Algorithm-based Tailoring of Dual Antiplatelet Therapy to Improve Outcomes Following Percutaneous Coronary Interventions
NA · 3 location(s) · Insel Gruppe AG, University Hospital Bern · NCT05732701Drug-Coated Balloon Versus Drug-Eluting Stent for Treatment of De-Novo Coronary Lesions in Patients With High Bleeding R
NA · 18 location(s) · Samsung Medical Center · NCT06742931STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for O
Phase 4 · 1 location(s) · Chinese Academy of Medical Sciences, Fuwai Hospital · NCT06901466Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease
NA · 2 location(s) · Massachusetts General Hospital · NCT07613840Optimal PERioperative Antiplatelet Therapy Investigation ON Abdominal Surgery After Coronary Stent Implantation
Phase 4 · 1 location(s) · Kyoto University · NCT06723145Pretreatment of Acute Coronary Syndrome With Dual Antiplatelet Agents
Phase N/A · 2 location(s) · Jordan Collaborating Cardiology Group · NCT07039149Transmission Electron Microscopy Images for Platelet Ultrastructural Criteria Before and After the Onset of an Antiplate
NA · 1 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT05004233Future Optimal Research and Care Evaluation
Phase N/A · 4 location(s) · J.M. ten Berg · NCT03823547Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO
NA · 1 location(s) · Fondazione Ricerca e Innovazione Cardiovascolare ETS · NCT06535568Development of a Device for Evaluating Primary Hemostasis Under Whole Blood Flow Conditions
Phase N/A · 2 location(s) · Centre Hospitalier Universitaire Dijon · NCT03773159STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients Without an Indication fo
Phase 4 · 1 location(s) · Chinese Academy of Medical Sciences, Fuwai Hospital · NCT07007143
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.